Tag: beta blocker

Posted on by — Leave a comment

Nebivolol | A Novel Beta Blocker

Town Pharmacy, nebivolol a novel beta blocker

Introduction
Nebivolol a novel beta blocker, available under the brand names of Nebil, Nebix and Byvas etc.  is more selective for beta1-adrenergic receptors than other drugs in this class and has a unique, not found in other beta-blockers now available to doctors, nitric oxide (NO)-potentiating, vasodilatory effect.

Nebivolol is a medication primarily used to treat hypertension (high blood pressure) and certain heart conditions. As a beta-blocker, it works by blocking the effects of adrenaline on the heart and blood vessels, resulting in decreased heart rate and relaxed blood vessels. In this blog post, we will delve into the details of nebivolol, exploring its uses, benefits, and potential side effects.

Definition and mechanism of action
Although the precise method by which beta-blockers lower blood pressure is not fully understood, possible processes include a heart-rate-related effect, suppression of the sympathetic nervous system, and inhibition of the renin-angiotensin system. A brand-new, highly selective beta-blocker with nonadrenergic vasodilating qualities is nebivolol. In Europe, it has been licenced for the treatment of congestive heart failure and essential hypertension, while the US is now reviewing it for the management of hypertension.

How it differs from other beta-blockers
According to clinical studies, nebivolol is ten times more effective than atenolol when compared on a weight-for-weight basis. In one study, using a double-blind, crossover design and a parallel, placebo group (n=7), the effects of doses of nebivolol (2.5 mg/day, 5.0 mg/day, and 10.0 mg/day) on exercise-induced increases in heart rate and blood pressure in 25 male hypertensive volunteers were compared with those of atenolol (50 mg/day and 100 mg/day) and of placebo. Nebivolol and atenolol both reduced heart rates (at rest and during submaximal activity) and sitting and standing diastolic and systolic blood pressures to the same extent at 24 hours following dose.

Approved medical conditions for nebivolol usage

Managing Hypertension with Nebivolol
Nebivolol as a first-line treatment for hypertension
Dosage and administration guidelines
Efficacy of nebivolol compared to other antihypertensive drugs
Nebivolol’s role in reducing cardiovascular events and mortality

Nebivolol for Heart Failure
Nebivolol’s unique properties for heart failure management
How nebivolol improves symptoms and quality of life in heart failure patients
Considerations and precautions when using nebivolol in heart failure patients

Potential Benefits Beyond Hypertension and Heart Failure
Exploring nebivolol’s role in endothelial dysfunction and vascular health
Nebivolol’s impact on nitric oxide production and vasodilation
Research on nebivolol’s potential for treating erectile dysfunction

Safety Profile and Side Effects
Common side effects of nebivolol and how to manage them
Rare but serious side effects and their associated risks
Precautions for specific patient populations (e.g., elderly, pregnant women, those with liver or kidney disease)

Drug Interactions and Contraindications
Medications that may interact with nebivolol
Contraindications and precautions for concurrent use of nebivolol with other drugs
Importance of consulting a healthcare professional before starting nebivolol

Patient Guidelines and Considerations
Recommendations for patients taking nebivolol
Importance of regular monitoring and follow-up appointments
Lifestyle modifications to complement nebivolol therapy (e.g., diet, exercise, stress management)

Recent studies on nebivolol’s effects on arterial stiffness and endothelial function
Potential role of nebivolol in reducing inflammation and oxidative stress
Emerging research on nebivolol’s impact on neuroprotection and cognitive function
Investigating the use of nebivolol in combination with other drugs for enhanced therapeutic outcomes

Comparing Nebivolol to Other Beta-Blockers
Differentiating nebivolol from other commonly used beta-blockers
Comparative efficacy, safety, and side effect profiles
Factors to consider when choosing between nebivolol and other beta-blockers for specific patient populations

Nebivolol in Special Populations
Nebivolol usage in the elderly population: benefits and considerations
Nebivolol safety and effectiveness in pregnant and breastfeeding women
Adjusting nebivolol dosage in patients with impaired liver or kidney function
Nebivolol use in pediatric patients: current evidence and potential applications

Personal Experiences and Testimonials
Real-life stories and experiences from patients using nebivolol
Insights into the impact of nebivolol on their daily lives and overall well-being
Patient perspectives on managing side effects and adhering to nebivolol therapy

Can nebivolol be used for anxiety or migraines?
What should I do if I miss a dose of nebivolol?
Can nebivolol cause weight gain?
Is nebivolol safe for long-term use?

Conclusion
Nebivolol is a valuable medication used in the management of hypertension, heart failure, and potentially other conditions. Its unique mechanism of action and favorable safety profile make it a popular choice among healthcare professionals. However, like any medication, nebivolol has potential side effects and interactions that should be considered. It is important for patients to work closely with their healthcare providers to determine the appropriate dosage, monitor for adverse effects, and optimize its benefits. By understanding nebivolol’s uses, benefits, and precautions, patients can make informed decisions and enhance their overall cardiovascular health.
Recap of key points discussed throughout the blog post
Encouragement for readers to consult healthcare professionals for personalized advice
Acknowledgment of nebivolol’s significant contribution to the field of cardiovascular medicine
Hope for continued research and advancements in the understanding of nebivolol’s benefits and potential applications
By expanding on these additional sections, the blog post will provide a more comprehensive overview of nebivolol, covering its latest research, comparisons with other beta-blockers, considerations for special populations, and real-life experiences from patients. This well-rounded perspective will equip readers with a deeper understanding of nebivolol’s uses, benefits, and potential implications for their cardiovascular health.

Posted on by

Propranolol | A Beta-Adrenergic Receptor Antagonist

propranolol inderal

 

IntroductionPropranolol, available under the brand name of Inderal is  a non-selective beta adrenergic antagonist is used to treat a variety of conditions, including hypertension, angina, atrial fibrillation, myocardial infarction, migraine, essential tremor, and hypertrophic subaortic stenosis.
PharmacodynamicsPropranolol belongs to a beta-adrenergic receptor antagonist is used to treat hypertension. Given once or twice daily, depending on the indication, propranolol has a long duration of action. Patients who quit taking propranolol abruptly risk worsening of their angina and myocardial infarctions.
The S(-)-enantiomer of propranolol, a racemic combination of two enantiomers, has roughly 100 times the binding affinity for beta adrenergic receptors than the R(-)-enantiomer. 9 The most prevalent illness for which propranolol is prescribed is hypertension.
Mode of ActionNonselective beta-adrenoreceptor antagonist Propranolol is also categorized as a class II antiarrhythmic. It responds by competitively blocking the heart’s normal epinephrine and norepinephrine-induced beta-1 and beta-2 adrenergic activation.

On cardiac myocytes, including the sinoatrial and atrioventricular nodes, there are beta-1 receptors. These receptors are activated, which results in an increase in cyclic AMP and an increase in intracellular calcium. Increased muscle fiber contractility results from this mechanism. Beta-adrenergic receptor blockade causes the heart’s overall workload to be reduced, which in turn lowers oxygen consumption and causes myocardial remodeling. [8]
On the other hand, beta-2 receptor activation results in an increase in cyclic AMP, which activates protein kinase A and causes smooth muscle cells in many organs and arteries to relax. Therefore, there is a slight vasoconstriction when beta-2 receptors are inhibited. Due to this action, it can be difficult for asthmatics to administer emergency epinephrine since it prevents epinephrine from potentially binding to pulmonary receptors. [9] Beta-blockers have a Vd of approximately 4 to 6 L/kg and are well distributed throughout the body. They are also highly protein-bound.

IndicationsHypertension can be treated with propranolol. Additionally, myocardial infarction, atrial fibrillation, migraine, essential tremor, hypertrophic subaortic stenosis, pheochromocytoma, and proliferating infantile hemangioma are all conditions for which propranolol is prescribed.
Availability & UsageBeta-blockers are processed mostly in the liver, like the majority of drugs ( both the active and inactive compounds). Due to first-pass metabolism in the hepatic circulation, only around 25% of the medicine consumed enters the systemic circulation.

Propranolol’s active metabolite, 4-hydroxypropranolol, is created via hydroxylation with the help of the CYP2D6 enzyme.
Additionally, propranolol, like the majority of ingested drugs, is primarily eliminated by the kidneys, having a half-life of between 3 and 6 hours in people with healthy renal systems.

You can administer propranolol intravenously or orally. Continuous ECG monitoring should be done while a gradual infusion is administered intravenously. This method of administration is most frequently used in inpatient settings.

The dosage of propranolol varies, mainly depending on the ailment it is used to treat.

Side EffectsBradycardia, gastrointestinal problems, abdominal pain, nausea, erectile dysfunction, and wheezing/bronchospasms are some of the most typical side effects of using propranolol. Use of propranolol may also result in weariness, drowsiness, and cold extremities. Hallucinations, insulin resistance, and allergic reactions are a few severe side effects to be aware of. Before writing a propranolol prescription for a patient, prescribers must go over all the side effects with them.
Drug Interation
(while taking with other medicine)
Important WarningIn some cases, propranolol may result in heart failure. If you experience chest pain or discomfort, dilated neck veins, intense exhaustion, erratic breathing, an irregular heartbeat, swelling of the face, fingers, feet, or lower legs, or weight gain, consult your doctor immediately once.
Available BrandsInderal

 

Posted on by

Atenolol | A Second-Generation beta-1-selective adrenergic antagonist

 

IntroductionAtenolol, available under brand names of Tenormin, Blokium, Zafnol is Synthetic beta-1 selective blocker. Atenolol is used to treat hypertension, chronic angina, and to lower mortality in individuals with known or suspected myocardial infarction who are hemodynamically stable.
Class of MedicineAtenolol is a second-generation beta-1-selective adrenergic antagonist lowers myocardial contractility, blood pressure, and heart rate.
Mode of ActionBecause it selectively binds to the 1-adrenergic receptor as an antagonist up to a reported 26 fold more than 2 receptors, atenolol is a cardioselective beta-blocker. 15 Due to the greater population of this receptor in cardiac tissue, selective action at the 1 receptor results in cardioselectivity. Therapeutic doses can still cause some binding to 2 and potentially 3 receptors, but the effects caused by antagonising these receptors are greatly diminished compared to those caused by non-selective drugs. Due to the Gs coupling between the 1 and 2 receptors, inhibiting their activation decreases the activity of adenylyl cyclase and the downstream signalling that it produces via cyclic adenosine monophosphate and protein kinase A.
PKA is hypothesised to mediate the activation of ryanodine receptors and L-type calcium channels in cardiomyocytes by phosphorylating these proteins. The release of calcium from the sarcoplasmic reticulum (SR) and an increase in contractility can then be caused by the 16 L-type calcium channels, which can first cause an increase in intracellular calcium. By phosphorylating phospholamban, which in turn enhances the SR Ca2+ ATPase’s affinity to promote calcium reuptake into the SR, PKA also contributes to the termination of contraction. Additionally, it phophorylates troponin I to lessen the protein’s affinity for calcium. Both of these occurrences result in a contraction reduction, which when combined with the initial contraction increase, enables faster cycling and, as a result, a higher heart rate with increased contractility.
PKA is hypothesised to mediate the activation of L-type calcium channels and ryanodine receptors in cardiomyocytes by the phosphorylation of these proteins. The ryanodine receptors are then triggered to release calcium that has been held in the sarcoplasmic reticulum (SR), leading to enhanced contractility, after an initial spike in intracellular calcium is provided by 16 L-type calcium channels. The phosphorylation of phospholamban by PKA, which enhances the SR Ca2+ ATPase’s affinity to promote calcium absorption into the SR, contributes to the termination of contraction as well. In order to lessen troponin I’s affinity for calcium, it also phophorylates the protein. When combined with the initial rise in contraction, both of these occurrences result in a contraction reduction, enabling faster cycling and, as a result, a greater heart rate with increased contractility.
IndicationsA second-generation beta-1-selective adrenergic antagonist called atenolol is used to treat acute myocardial infarction, angina pectoris, and hypertension. Treatment of arrhythmias, migraine prevention, paroxysmal supraventricular tachycardia, alcohol withdrawal, thyrotoxicosis prevention, and prophylaxis against subsequent myocardial infarction are only a few of the non-FDA authorised uses. In cases of infantile hemangiomas, atenolol may also be used instead of propranolol, though further study is necessary before use.
Avaiability & UsageFor oral treatment, atenolol comes in 25 mg, 50 mg, and 100 mg tablets; 0.5 mg/mL is also available for intravenous injection. Depending on the indication, a different dosage and administration method is used.

Hypertension
Atenolol’s starting dose for adults is 50 mg per day, either either as a single tablet or along with diuretic medication. After a few weeks, if there hasn’t been a significant therapeutic response, the dosage may be increased to one 100 mg tablet taken once daily. Higher daily doses are unlikely to result in additional advantages.  If the patient has a creatinine clearance of less than 15 ml/min, a lower dose of 25 mg per day may be utilised for elderly or renally impaired patients. Before giving them a new dose, careful blood pressure monitoring is required.

Chronic chest pain
The initial adult dose for non-vasospastic angina is 50 mg once daily. One 100 mg pill should be used each day if, after a week, the patient has not had the best results. For the best therapeutic outcome, some patients could require 200 mg per day. The patient should be observed and told to reduce their physical activity during this period since withdrawal should be accomplished gradually. [

Myocardial Infarction Acute
Within 12 hours after the myocardial infarction, intravenous injection should take place as soon as the patient enters the hospital.

For instance, the FDA advises giving an adult a 5-minute IV atenolol injection followed by a 10-minute IV injection of another 5-mg dose. After 12 hours, an oral dose of 50 mg should be taken. Then, for the following 6 to 9 days or until the patient is discharged from the hospital, oral dose might be either 50 mg twice daily or 100 mg once daily.

Migraine Prevention
The initial adult dose is 25 mg once daily, which is increased to 100 mg once daily over the course of 1-2 weeks.

T-wave supraventricular rhythm
The first dose of atenolol for adults, as recommended by the ACC and AHA, is 25 to 50 mg per day, which is increased to 100 mg once daily based on tolerance and response.

Coronary infarction
Most patients should begin taking beta-blockers within 24 hours of their myocardial infarction, and they should continue taking them for secondary prophylaxis, gradually increasing their dose up to 50 mg twice day depending on their blood pressure, heart rate, and side effects.

Thyrotoxicosis
The initial dose is 25–50 mg once daily, which is increased as necessary to a maximum of 100 mg twice daily in order to treat tachycardia, palpitations, and trembling.

Employing in the Particular Patient Populations
Patients with hepatic impairment: The manufacturer’s labelling does not mention changing the dosage. Additionally, as was already mentioned, atenolol undergoes very little hepatic metabolism.
Patients with Impairment of Renal Function: Patients with impaired renal function should be watched closely, and the dose has to be changed in accordance with creatinine clearance.
No dose change is required if creatinine clearance is more than 30 mL/min.
Creatinine clearance 10–30 mL/min: 50 mg/day as the maximum dose.
Maximum dose up to 25 mg per day for creatinine clearance 10 mL/minute.
Those undergoing hemodialysis Hemodialysis effectively removes atenolol; provide atenolol after hemodialysis.

Considerations for Pregnancy:
Former FDA pregnancy category D drug is atenolol. [19] Atenolol is not advised during pregnancy, under the recommendations of The American College of Obstetricians and Gynecologists (ACOG), due to the possibility of growth restriction and low birth weight. Labetalol is the chosen beta blocker for pregnant women with persistent hypertension.

Considerations When Breastfeeding: Plasma protein binding is primarily responsible for the excretion of beta blockers in breast milk Drugs like atenolol (10% PPB), which have low plasma protein binding, are extensively excreted in breast milk.

Side EffectsThe following are atenolol’s side effects, per the product label.

Avoid stopping atenolol suddenly because doing so could make your angina, acute myocardial infarction, or ventricular arrhythmias worse. It is advised that the dose be reduced gradually.
It is advised that atenolol be swiftly reintroduced briefly if angina worsens or acute coronary insufficiency develops.
Bradycardia, dizziness, constipation, confusion, dyspnea, headaches, erectile dysfunction, nausea, lethargy, paraesthesia, peripheral numbness, rash, sleep disturbances, syncope, visual impairment, and bronchospasm are a few of the more typical adverse effects.
Alopecia, dry mouth, postural hypotension, psychosis, psoriasis, thrombocytopenia, depression, moderate transaminitis, and depression are uncommon adverse reactions.
Severe bradycardia, renal failure, atrioventricular blockage, shock, and hyperkalemia are the traits of the BRASH syndrome. If you suspect BRASH syndrome, stop taking atenolol.

Drug Interaction
CautionIn some cases, atenolol may result in cardiac failure. If you experience discomfort or pain in your chest, consult a doctor right once; Swelling of the face, fingers, feet, or lower legs; dilated neck veins; extreme fatigue; irregular breathing; an irregular heartbeat; weight gain; or wheezing
Available BrandsTenormin
Blokium
Zafnol